Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Tokyo, Friday, 10 February 2023 - Returning this October, the Citeline Pharma Intelligence Awards Japan will gather together hundreds of industry leaders to recognize the latest outstanding contributions and innovative breakthroughs in Japanese pharma and biotech.
These trusted awards provide a platform for global recognition and the acknowledgement of standout organizations and products across eight distinct categories - from Best Contract Research Organization, Best New Drug, to Biotech Company of the Year. New for 2023, the Financing Deal of the Year category will shine a light on successful fundraising strategies in drug discovery and company development.
View the full list of categories for 2023 here.
Ian Haydock, APAC Editor-in-Chief at Citeline Pharma Intelligence: “Innovation has a dramatic effect on the health of millions of patients around the world. After the success of last year’s inaugural awards, we’re looking forward to uniting the industry again to showcase a new group of pioneers in Japanese pharma and biotech.”
Applicants are welcomed from any pharmaceutical or biotech company operating in Japan, or those primarily doing business in Japan. Entries are confidential, with all judges required to sign a confidentiality agreement.
Entries are now open and will close on Monday, 10 July 2023. Judging will take place over August and September and the winners will be announced at a prestigious networking dinner and ceremony at the Palace Hotel in Tokyo on Tuesday, 17 October 2023.
For more information on the Awards, including entry guidelines, please visit: pharmaintelligence.informa.com/citelinepharmaintelligenceawards2023
Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory related-decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
For more information on one of the world’s most trusted health science partners, visit: https://www.citeline.com/comingsoon/
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: